BFAM
Bright Horizons Family Solutions Inc.
BFAM has lower modeled downside risk, despite its lower overall score.
TSLA
Tesla, Inc.
TSLA has the edge over BFAM overall, supported by stronger fundamentals.
BFAM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Weak |
BFAM's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
BFAM PE Valuation
BFAM has no meaningful PE right now: it lost money over the past year.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
BFAM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect BFAM's earnings to grow and its profitability to improve, with its revenue holding steady.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
BFAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.47 | — |
| Q3 2026 | -$2.97 | -185% |
| Q2 2026 | $3.16 | +3.6% |
| Q1 2026 | $3.32 | +20% |
| Q4 2025 | $3.36 | +40% |
| Q3 2025 | $3.48 | +74% |
| Q2 2025 | $3.05 | +74% |
| Q1 2025 | $2.77 | +94% |
| Q4 2024 | $2.40 | +88% |
BFAM has swung to a loss: it lost $2.97 per share over the past year, after a profit the year before.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA has the edge over BFAM on earnings quality, reporting a profit while its opponent remains loss making.
BFAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $841.5M | +4.8% |
| Q2 2026 | $779.2M | +6.5% |
| Q1 2026 | $712.2M | +7% |
| Q4 2025 | $733.7M | +8.8% |
| Q3 2025 | $802.8M | +12% |
| Q2 2025 | $731.6M | +9.2% |
| Q1 2025 | $665.5M | +6.9% |
| Q4 2024 | $674.1M | +9.5% |
BFAM has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -22% | -37 points |
| Q2 2026 | 10% | -1.5 points |
| Q1 2026 | 9.1% | -0.2 points |
| Q4 2025 | 6.2% | -1 points |
| Q3 2025 | 15% | +2.6 points |
| Q2 2025 | 12% | +1.4 points |
| Q1 2025 | 9.4% | +2.9 points |
| Q4 2024 | 7.2% | +2.6 points |
BFAM's operating margin was −22% last quarter, down 37 points from the same quarter a year ago, near the bottom of its range since 2019.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA has the edge over BFAM on profitability, with a higher operating margin.
BFAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$25.1M | +$17.4M |
| Q2 2026 | $76.1M | -34% |
| Q1 2026 | $87.6M | +23% |
| Q4 2025 | $114.7M | +29% |
| Q3 2025 | -$42.4M | -$10.3M |
| Q2 2025 | $115.4M | +33% |
| Q1 2025 | $70.9M | -27% |
| Q4 2024 | $88.6M | +37% |
BFAM has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
BFAM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 9.5x | High |
| Q2 2026 | 2.3x | Moderate |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.4x | Moderate |
BFAM's net debt is about 9.5 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over BFAM on leverage, with a lower net debt burden relative to earnings.
BFAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 7.9 | Oversold |
BFAM's weekly RSI is 30 (neutral) and its Stochastic is 8 (oversold).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
BFAM PE vs Consumer Cyclical Sector
| Metric | BFAM | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 25% above |
| PE % | 6 | 47 | 41 pts below |
BFAM has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
BFAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.9 | 16% below |
| 20 week MA | $68.6 | 23% below |
| 50 week MA | $76.3 | 31% below |
| 100 week MA | $96.6 | 45% below |
| 200 week MA | $98.9 | 47% below |
BFAM is in a downtrend: it's below all five of its weekly moving averages, and 47% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over BFAM on trend strength, trading above more of its moving averages.
BFAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $150.9 | $165.3 | +9.6% |
| 2021 | $165.3 | $123.2 | -25% |
| 2022 | $123.2 | $59.9 | -51% |
| 2023 | $59.9 | $94.2 | +57% |
| 2024 | $94.2 | $110.5 | +17% |
| 2025 | $110.5 | $101.3 | -8.3% |
| 2026 YTD | $101.3 | $52.8 | -48% |
BFAM has finished lower in three of the last six years. It's down 48% so far in 2026.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over BFAM on returns for 2026, with the stronger performance.